Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

2008208 citationsJournal Article

Authors

Good health and well-being

Published in: Leukemia

Volume 22, Issue 10, pp. 1925-1932

Field-Weighted Citation Impact: 10.51